Insider trades

Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.

Open-market buys
923 trades
$2B in total
Open-market sales
1,038 trades
$2.3B in total
Insiders filing
464 insiders
Last 7 days
Trade type
10% Owner
Telomir PharmaceuticalsTELO
Open-market buy24/02/1324/02/15138,000 sh3 trades$7.00avg.$966,000+7.8%
10% Owner
Telomir PharmaceuticalsTELO
Open-market buy24/02/1324/02/15138,000 sh3 trades$7.00avg.$966,000+7.8%